Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-03-01 vs Minoxidil in male androgenetic alopecia
NCT02279823Phase 2Completed
- Sponsor
- Intrepid Therapeutics, Inc.
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clascoterone in androgenetic alopecia (AGA), sponsored by Intrepid Therapeutics, Inc.. Started Oct 2014; status: completed.
02
Drugs
clascoterone
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02279823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279823.